Mineralys Therapeutics Unveils Trial Results Showcase Lorundrostat in Hypertension Treatment
DENVER, Colo., Mar 10, 2025 (247marketnews.com)- Mineralys Therapeutics (NASDAQ:MLYS) reported positive topline results from its pivotal Launch-HTN Phase 3 and...